· Chongqing Kanghua Zhonglian Cardiovascular Hospital (abbreviated as "Chongqing Kangxin Hospital") is a tertiary-level, specialised cardiovascular hospital constructed to international standards. As a key investment project introduced through the Chongqing International Investment and Global Sourcing Fair (CIIGSF) and the first specialised cardiovascular hospital in Chongqing, it represents a total investment exceeding RMB 1.2 billion. With a total GFA of 100,000 sqm and planned capacity of 800 beds, the hospital is able to draw on international management experience to continuously strengthen regional high-end medical service capabilities.
· Since opening on 1 March 2017, Chongqing Kangxin Hospital has established a comprehensive diagnosis and treatment system covering the full spectrum of cardiovascular diseases. The center specialises in precision medicine for structural heart disease, complex coronary artery disease, life-threatening arrhythmias, and major vascular disorders. The core clinical team comprises leading experts from China's top cardiovascular institutions, including Xinqiao Hospital of Army Medical University, Southwest Hospital and General Hospital of Northern Theater Command.
· The hospital has innovatively implemented a dual-track talent structure combining "Chief Medical Officer + Specially-Appointed Experts". With Professor Ma Changsheng, the Chief Medical Officer of Chongqing Kangxin Hospital, also a renowned cardiologist and Director of the Cardiology Centre at Beijing Anzhen Hospital Affiliated to Capital Medical University the leadership is complemented by a specially-appointed expert team comprising multiple national-level academic leaders, forming sustainable mechanisms for regular clinical consultations, surgical guidance, and collaborative research initiatives.
